2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2/3
1
Status
Completed
26
Unknown
10
Recruiting
6
Withdrawn
3
Terminated
2
Not yet recruiting
2
Active not recruiting
2
Enrolling by invitation
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Breast Neoplasms
1127
Neoplasms
982
Carcinoma, Non-Small-Cell Lung
900
Prostatic Neoplasms
594
Neoplasm Metastasis
528
Leukemia, Myeloid, Acute
513
Colorectal Neoplasms
491
Lung Neoplasms
487
Melanoma
485
Multiple Myeloma
477
Pancreatic Neoplasms
385
Lymphoma
369
Ovarian Neoplasms
368
Recurrence
365
Lymphoma, Non-Hodgkin
346
Leukemia
339
Leukemia, Lymphocytic, Chronic, B-Cell
321
Precursor Cell Lymphoblastic Leukemia-Lymphoma
291
Head and Neck Neoplasms
276
Carcinoma, Renal Cell
276
Brain Neoplasms
273
Carcinoma, Hepatocellular
261
Glioblastoma
249
Lymphoma, Large B-Cell, Diffuse
244
Myelodysplastic Syndromes
242
Squamous Cell Carcinoma of Head and Neck
241
Lymphoma, Follicular
236
Colonic Neoplasms
214
Stomach Neoplasms
200
Rectal Neoplasms
190
Interventions
Gentamicins
1
Colistin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Sepsis
×
Clear all
NCT04203524
2025-03-17
Pro-Can
King Hussein Cancer Center
Phase NA
Terminated
157 enrolled
NCT01931592
2017-05-08
CLEAR
University of Cologne
Phase 2/3
Terminated
29 enrolled